from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3416/whiB3

LFCtreatmentdescriptionclass of inhibitor

-0.390

Amikacinug/mL Amikacintranslation

0.939

Cap5-10ug/mL Capreomycintranslation

1.234

Rox10-50 ug/mL Roxithromycintranslation

-0.209

SM2-5 ug/mL Streptomycintranslation

0.401

Tet5-10 ug/mL Tetracyclinetranslation

-0.471

Rif0.2-5ug/mL Rifampicintranscription

-0.531

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.984

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.080

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.273

CPZ10-50 ug/mL Chlorpromazinerespiration

0.717

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.303

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.458

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.593

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.466

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.015

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.137

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.014

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.609

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.178

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.642

KCN5-20 ug/mL Potassium cyaniderespiration

-0.191

NaN30.2-2 mM Sodium aziderespiration

-0.213

Nigericin50 uM Nigericinrespiration

-0.119

TRC10-150 ug/mL Triclosanrespiration

0.126

TRZ10-25 ug/mL Thioridazinerespiration

0.632

Valinomycin0.5-10 uM Valinomycinrespiration

0.134

ZnSO42 mM ZnSO4respiration

0.720

menadione6-10 ug/mL Menadionerespiration

0.337

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.430

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.305

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.360

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

2.148

NRP_1Non-replicating persistence stage 1dosRassociated

-0.143

Amp0.2mg/mL AmpicillincellWall

-0.356

Cephalexin20-100 ug/mL CephalexincellWall

-0.092

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.352

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.187

EMB10-20 ug/mL EthambutolcellWall

-0.003

Eta12-40 ug/mL EthionamidecellWall

-0.053

INH0.2-0.4 ug/mL IsoniazidcellWall

0.192

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.708

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.200

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.572

BZA0.12 mg/mL BenzamidearomaticAmides

-1.495

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-1.425

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.088

H2O24 mM hydrogen peroxideDNAdamaging

-0.190

Levo10 ug/mL LevofloxacinDNAdamaging

-0.100

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.910

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.485

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.227

UVUV-irradiationDNAdamaging

0.748

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.143

Antimycin12.5-50 ug/mL Antimycin A?

-0.391

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.487

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.560

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.083

PA8240.2-2 ug/mL PA-824?

0.263

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.035

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.061

Verapamil50 uM Verapamil?

-0.487

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.179

methoxatin10-20 ug/mL Methoxatin?